|
1
|
Kreidberg JA, Sariola H, Loring JM, Maeda
M, Pelletier J, Housman D and Jaenisch R: WT-1 is required for
early kidney development. Cell. 74:679–691. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim MK, McGarry TJ, O Broin P, Flatow JM,
Golden AA and Licht JD: An integrated genome screen identifies the
Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci
USA. 106:11154–11159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Little NA, Hastie ND and Davies RC:
Identification of WTAP, a novel Wilms' tumour 1-associating
protein. Hum Mol Genet. 9:2231–2239. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Granadino B, Penalva LO and Sánchez L: The
gene fl(2)d is needed for the sex-specific splicing of transformer
pre-mRNA but not for double-sex pre-mRNA in Drosophila
melanogaster. Mol Gen Genet. 253:26–31. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Penalva LO, Ruiz MF, Ortega A, Granadino
B, Vicente L, Segarra C, Valcárcel J and Sánchez L: The drosophila
fl(2) d gene, required for female-specific splicing of Sxl and tra
pre-mRNAs, encodes a novel nuclear protein with a HQ-rich domain.
Genetics. 155:129–139. 2000.PubMed/NCBI
|
|
6
|
Horiuchi K, Umetani M, Minami T, Okayama
H, Takada S, Yamamoto M, Aburatani H, Reid PC, Housman DE, Hamakubo
T and Kodama T: Wilms' tumor 1-associating protein regulates G2/M
transition through stabilization of cyclin A2 mRNA. Proc Natl Acad
Sci USA. 103:17278–17283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Naruse C, Fukusumi Y, Kakiuchi D and Asano
M: A novel gene trapping for identifying genes expressed under the
control of specific transcription factors. Biochem Biophys Res
Commun. 361:109–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horiuchi K, Kawamura T, Iwanari H, Ohashi
R, Naito M, Kodama T and Hamakubo T: Identification of Wilms' tumor
1-associating protein complex and its role in alternative splicing
and the cell cycle. J Biol Chem. 288:33292–33302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schwartz S, Mumbach MR, Jovanovic M, Wang
T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N,
Cacchiarelli D, et al: Perturbation of m6A writers reveals two
distinct classes of mRNA methylation at internal and 5′ sites. Cell
Rep. 8:284–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ping XL, Sun BF, Wang L, Xiao W, Yang X,
Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, et al: Mammalian WTAP is
a regulatory subunit of the RNA N6-methyladenosine
methyltransferase. Cell Res. 24:177–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jo HJ, Shim HE, Han ME, Kim HJ, Kim KS,
Baek S, Choi KU, Hur GY and Oh SO: WTAP regulates migration and
invasion of cholangiocarcinoma cells. J Gastroenterol.
48:1271–1282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin DI, Lee SW, Han ME, Kim HJ, Seo SA,
Hur GY, Jung S, Kim BS and Oh SO: Expression and roles of Wilms'
tumor 1-associating protein in glioblastoma. Cancer Sci.
103:2102–2109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bansal H, Yihua Q, Iyer SP, Ganapathy S,
Proia DA, Penalva LO, Uren PJ, Suresh U, Carew JS, Karnad AB, et
al: WTAP is a novel oncogenic protein in acute myeloid leukemia.
Leukemia. 28:1171–1174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang
K, Go MY, Ng SC, Chan FK, Sung JJ and Yu J: Carbonic anhydrase IV
inhibits colon cancer development by inhibiting the Wnt signalling
pathway through targeting the WTAP-WT1-TBL1 axis. Gut. pii:
gutjnl-2014-308614. 2015.Epub ahead of print.
|
|
15
|
Ding Z, Yang HW, Xia TS, Wang B and Ding
Q: Integrative genomic analyses of the RNA-binding protein, RNPC1,
and its potential role in cancer prediction. Int J Mol Med.
36:473–484. 2015.PubMed/NCBI
|
|
16
|
Wang B, Xu W, Tan M, Xiao Y, Yang H and
Xia TS: Integrative genomic analyses of a novel cytokine,
interleukin-34 and its potential role in cancer prediction. Int J
Mol Med. 35:92–102. 2015.
|
|
17
|
Yang L, Luo Y and Wei J: Integrative
genomic analyses on Ikaros and its expression related to solid
cancer prognosis. Oncol Rep. 24:571–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Luo Y, Wei J and He S: Integrative
genomic analyses on IL28RA, the common receptor of
interferon-lambda1, -lambda2 and -lambda3. Int J Mol Med.
25:807–812. 2010.PubMed/NCBI
|
|
19
|
Yang L, Wei J and He S: Integrative
genomic analyses on interferon-lambdas and their roles in cancer
prediction. Int J Mol Med. 25:299–304. 2010.PubMed/NCBI
|
|
20
|
Wang M, Wei X, Shi L, Chen B, Zhao G and
Yang H: Integrative genomic analyses of the histamine H1 receptor
and its role in cancer prediction. Int J Mol Med. 33:1019–1026.
2014.PubMed/NCBI
|
|
21
|
Wang B, Chen K, Xu W, Chen D, Tang W and
Xia TS: Integrative genomic analyses of secreted protein acidic and
rich in cysteine and its role in cancer prediction. Mol Med Rep.
10:1461–1468. 2014.PubMed/NCBI
|
|
22
|
Kumar S, Nei M, Dudley J and Tamura K:
MEGA: A biologist-centric software for evolutionary analysis of DNA
and protein sequences. Brief Bioinform. 9:299–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Z: PAML: A program package for
phylogenetic analysis by maximum likelihood. Comput Appl Biosci.
13:555–556. 1997.PubMed/NCBI
|
|
24
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: Mining complete cancer genomes in the catalogue of somatic
mutations in cancer. Nucleic Acids Res. 39(Database issue):
D945–D950. 2011. View Article : Google Scholar :
|
|
25
|
Chalifa-Caspi V, Yanai I, Ophir R, Rosen
N, Shmoish M, Benjamin-Rodrig H, Shklar M, Stein TI, Shmueli O,
Safran M and Lancet D: GeneAnnot: Comprehensive two-way linking
between oligonucleotide array probesets and GeneCards genes.
Bioinformatics. 20:1457–1458. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parkinson H, Sarkans U, Shojatalab M,
Abeygunawardena N, Contrino S, Coulson R, Farne A, Lara GG,
Holloway E, Kapushesky M, et al: ArrayExpress-a public repository
for microarray gene expression data at the EBI. Nucleic Acids Res.
33(Database issue): D553–D555. 2005. View Article : Google Scholar
|
|
27
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2:182009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS,
Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, et al: Predictive value
of progression-related gene classifier in primary non-muscle
invasive bladder cancer. Mol Cancer. 9:32010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Freije WA, Castro-Vargas FE, Fang Z,
Horvath S, Cloughesy T, Liau LM, Mischel PS and Nelson SF: Gene
expression profiling of gliomas strongly predicts survival. Cancer
Res. 64:6503–6510. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pawitan Y, Bjöhle J, Amler L, Borg AL,
Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, et al: Gene
expression profiling spares early breast cancer patients from
adjuvant therapy: Derived and validated in two population-based
cohorts. Breast Cancer Res. 7:R953–R964. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sotiriou C, Wirapati P, Loi S, Harris A,
Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, et al:
Gene expression profiling in breast cancer: Understanding the
molecular basis of histologic grade to improve prognosis. J Natl
Cancer Inst. 98:262–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jorissen RN, Gibbs P, Christie M, Prakash
S, Lipton L, Desai J, Kerr D, Aaltonen LA, Arango D, Kruhøffer M,
et al: Metastasis-associated gene expression changes: Predict poor
outcomes in patients with dukes stage B and C colorectal cancer.
Clin Cancer Res. 15:7642–7651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar
|
|
34
|
Laurent C, Valet F, Planque N, Silveri L,
Maacha S, Anezo O, Hupe P, Plancher C, Reyes C, Albaud B, et al:
High PTP4A3 phosphatase expression correlates with metastatic risk
in uveal melanoma patients. Cancer Res. 71:666–674. 2011.
View Article : Google Scholar
|
|
35
|
Tomida S, Takeuchi T, Shimada Y, Arima C,
Matsuo K, Mitsudomi T, Yatabe Y and Takahashi T: Relapse-related
molecular signature in lung adenocarcinomas identifies patients
with dismal prognosis. J Clin Oncol. 27:2793–2799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar
|
|
37
|
Bild AH, Yao G, Chang JT, Wang Q, Potti A,
Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al:
Oncogenic pathway signatures in human cancers as a guide to
targeted therapies. Nature. 439:353–357. 2006. View Article : Google Scholar
|
|
38
|
Gobble RM, Qin LX, Brill ER, Angeles CV,
Ugras S, O'Connor RB, Moraco NH, Decarolis PL, Antonescu C and
Singer S: Expression profiling of liposarcoma yields a multigene
predictor of patient outcome and identifies genes that contribute
to liposarcomagenesis. Cancer Res. 71:2697–2705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Y, Wang J, Li X, Jia Y, Huai L, He K,
Yu P, Wang M, Xing H, Rao Q, et al: Role of the Wilms' tumor 1 gene
in the aberrant biological behavior of leukemic cells and the
related mechanisms. Oncol Rep. 32:2680–2686. 2014.PubMed/NCBI
|
|
40
|
Lee SY, Choe YJ, Park JY, Lee SS, Kim YH,
Shin SJ, Chung YJ and Kim HS: Wilms' tumor gene 1 enhances
nutlin-3-induced apoptosis. Oncol Rep. 31:131–136. 2014.
|
|
41
|
Liu Y and Liu S: Berberine inhibits Wilms'
tumor cell progression through upregulation of Wilms' tumor gene on
the X chromosome. Mol Med Rep. 8:1537–1541. 2013.PubMed/NCBI
|
|
42
|
Li M, Cai MY, Lu JB, Hou JH, Wu QL and Luo
RZ: Clinicopathological investigation of four cases of desmoplastic
small round cell tumor. Oncol Lett. 4:423–428. 2012.
|
|
43
|
Ding Y, Yang M, She S, Min H, Xv X, Ran X,
Wu Y, Wang W, Wang L, Yi L, et al: iTRAQ-based quantitative
proteomic analysis of cervical cancer. Int J Oncol. 46:1748–1758.
2015.PubMed/NCBI
|
|
44
|
Kaewpiboon C, Srisuttee R, Malilas W, Moon
J, Oh S, Jeong HG, Johnston RN, Assavalapsakul W and Chung YH:
Upregulation of Stat1-HDAC4 confers resistance to etoposide through
enhanced multidrug resistance 1 expression in human A549 lung
cancer cells. Mol Med Rep. 11:2315–2321. 2015.
|
|
45
|
Chen S, Li C, Wu B, Zhang C, Liu C, Lin X,
Wu X, Sun L, Liu C, Chen B, et al: Identification of differentially
expressed genes and their subpathways in recurrent versus primary
bone giant cell tumors. Int J Oncol. 45:1133–1142. 2014.PubMed/NCBI
|
|
46
|
Li W, Wei Q and Liang J: Phosphorylated
signal transducer and activator of transcription 1 is a potential
predictor of interferon response in patients with advanced renal
cell carcinoma. Mol Med Rep. 9:1929–1934. 2014.PubMed/NCBI
|
|
47
|
Zhao Z, Li C, Xi H, Gao Y and Xu D:
Curcumin induces apoptosis in pancreatic cancer cells through the
induction of forkhead box O1 and inhibition of the PI3K/Akt
pathway. Mol Med Rep. 12:5415–5422. 2015.PubMed/NCBI
|
|
48
|
Gao F and Wang W: MicroRNA-96 promotes the
proliferation of colorectal cancer cells and targets tumor protein
p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1)
and FOXO3a. Mol Med Rep. 11:1200–1266. 2015.
|
|
49
|
Zhu H: Targeting forkhead box
transcription factors FOXM1 and FOXO in leukemia (Review). Oncol
Rep. 32:1327–1334. 2014.PubMed/NCBI
|
|
50
|
Xu Y, Wang W, Gou A, Li H, Tian Y, Yao M
and Yang R: Effects of suppressor of cytokine signaling 1 silencing
on human melanoma cell proliferation and interferon-γ sensitivity.
Mol Med Rep. 11:583–588. 2015.
|
|
51
|
Chen FF, Jiang G, Xu K and Zheng JN:
Function and mechanism by which interferonregulatory factor-1
inhibits oncogenesis. Oncol Lett. 5:417–423. 2013.PubMed/NCBI
|
|
52
|
Pufall MA: Glucocorticoids and Cancer. Adv
Exp Med Biol. 872:315–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Volden PA and Conzen SD: The influence of
glucocorticoid signaling on tumor progression. Brain Behav Immun.
30(Suppl): S26–S31. 2013. View Article : Google Scholar
|
